Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1651 1653 1796
This examiner grants 46% of resolved cases
Emily Fay Eix is an examiner in Tech Center 1700 and Art Unit 1651. She has 33 resolved cases, which provide the data for her prosecution profile. Her allowance rate is 45.5 percent, indicating the baseline frequency of granted patents for applications under her review. This 45.5 percent rate suggests an examination environment where success depends on effective negotiation and technical clarity.
The interview lift is 78.3 percent, which is a metric for practitioners to consider. This 78.3 percent lift indicates that conducting an interview has a high impact on the likelihood of reaching an allowance. The data suggests that verbal communication is a component of a successful strategy when working with this examiner in Art Unit 1651.
The median time to reach an allowance is 1295 days for cases that are successfully prosecuted. This 1295-day duration serves as a benchmark for applicants to estimate the total time required to secure a patent. Given the 78.3 percent interview lift, practitioners should prioritize early engagement to navigate the 1295-day process more effectively.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18012916 | NOVEL METHOD OF MEASURING ENZYME ACTIVITY | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18723030 | METHOD FOR STORING REDUCED COENZYME Q10 | Non-Final OA | KANEKA CORPORATION |
| 18708496 | MUTANT ACE2 PROTEINS AND METHODS OF USING SAME | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18026860 | METHOD FOR RECOVERING A PROTEIN FROM A FERMENTATION BROTH COMPRISING A HIGH DEGREE OF LYSED CELLS | Final Rejection | BASF SE |
| 18173620 | WASHING OR CLEANING AGENT COMPRISING A PROTEASE AND AN AMYLASE | Non-Final OA | BASF SE |
| 18259153 | ENZYMATIC RECYCLING OF POLYURETHANES BY A COMBINATION OF CUTINASES AND ESTERASES | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18229592 | USE OF INTESTINAL PROBIOTIC IN PREPARATION OF MEDICAMENT THAT PROMOTES METABOLISM OF ELLAGIC ACID INTO UROLITHIN A, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Final Rejection | Zhejiang University |
| 18559244 | METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC PROSTATITIS AND/OR CHRONIC PELVIC PAIN SYNDROME | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 18005826 | ENGINEERED N-GLYCOSYLTRANSFERASES WITH ALTERED SPECIFICITIES | Final Rejection | Northwestern University |
| 17431813 | BEE GUT MICROBIAL FORMULATION FOR USE AS A PROBIOTIC FOR IMPROVED BEE HEALTH AND PATHOGEN RESISTANCE | Non-Final OA | Board of Regents, The University of Texas System |
| 17915405 | CELL CAPSULATING LAYER, CAPSULATED CELLS, CELL CAPSULATING COMPOSITION AND PREPARATION METHOD THEREFOR | Final Rejection | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18267958 | Microbial Cells Possessing a Reduced Lactose Internalization For Producing an Oligosaccharide | Final Rejection | Chr. Hansen A/S |
| 18553310 | CHONDROITIN-PRODUCING RECOMBINANT CELL | Non-Final OA | GIVAUDAN SA |
| 18029224 | ENGINEERED STABLE LACTATE OXIDOREDUCTASES, COMPOSITIONS, DEVICES, KITS AND USES THEREOF | Final Rejection | National University Corporation Tokyo University of Agriculture and Technology |
| 18288797 | Pharmaceutical Composition for Improving and Treating Leukotrichia and/or Alopecia and Preparation Method Thereof | Non-Final OA | Beijing University of Chemical Technology |
| 18253585 | METHODS OF IMPROVING PRODUCTION OF MORPHINAN ALKALOIDS AND DERIVATIVES | Non-Final OA | ANTHEIA, INC. |
| 17995352 | METHOD FOR PRODUCING HEPAROSAN AND BACTERIUM OF GENUS ESCHERICHIA HAVING HEPAROSAN-PRODUCING ABILITY | Non-Final OA | KIRIN BIOMATERIALS CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy